Pathophysiology of proteinuria.

Area of Science:

• Nephrology
• Pathophysiology
• Biomarker Discovery

Background:

• Proteinuria arises from glomerular barrier dysfunction and proximal tubule reabsorption impairment.
• Glomerular diseases increase permeability, allowing high-molecular-weight (HMW) proteins to pass.
• Impaired reabsorption and potential tubule damage lead to excretion of both HMW and low-molecular-weight (LMW) proteins.

Purpose of the Study:

• To investigate the correlation between urinary protein excretion and glomerular disease severity.
• To evaluate the predictive value of specific urinary proteins for disease course and treatment response.

Main Methods:

• Analysis of urinary excretion of HMW proteins (IgG, IgM) and LMW proteins (alpha1-microglobulin, beta2-microglobulin) in patients with glomerular diseases.
• Correlation of protein excretion levels with histological lesion severity and clinical outcomes.

Main Results:

• Urinary excretion of specific HMW and LMW proteins correlates with histological damage in glomerular diseases.
• These protein markers may predict disease progression, outcome, and treatment response more effectively than total proteinuria.
• Elevated urinary HMW and LMW proteins suggest pre-existing, potentially irreversible, damage to glomerular and tubulointerstitial structures.

Conclusions:

• Urinary HMW and LMW protein profiles offer valuable insights into glomerular disease severity and prognosis.
• These proteins serve as potential biomarkers for predicting disease trajectory and guiding therapeutic strategies.
• Early detection of structural kidney damage may be indicated by elevated urinary HMW and LMW protein levels.